Literature DB >> 24368743

Laparoscopic cytoreductive surgery and early postoperative intraperitoneal chemotherapy for patients with colorectal cancer peritoneal carcinomatosis: initial results from a single center.

Soo Yeun Park1, Gyu-Seog Choi, Jun Seok Park, Hye Jin Kim, Jong-Pil Ryuk, Sung-Hwan Yun, Jong Gwang Kim, Byung Woog Kang.   

Abstract

BACKGROUND: In recent decades, a combination of cytoreductive surgery and intraperitoneal chemotherapy has yielded improvements in the survival of patients with peritoneal carcinomatosis. Laparoscopic cytoreductive surgery and intraperitoneal chemotherapy comprise a challenging and rarely reported surgical procedure.
METHODS: Between November 2004 and February 2010, 29 patients underwent cytoreductive surgery and early postoperative intraperitoneal chemotherapy for peritoneal carcinomatosis secondary to colorectal cancer. Of the 29 patients, 15 underwent laparoscopic surgery and 14 underwent open surgery.
RESULTS: The patient characteristics did not differ significantly between the two groups. Synchronous peritoneal carcinomatosis with a primary tumor was more common in the laparoscopic group, and the Gilly stage of peritoneal carcinomatosis was found more frequently in the open group. Complication rate and hospital stay were less in the laparoscopic group. However, the outcomes for the patients undergoing the combined treatment were similar between the two groups with respect to completeness of cytoreduction, operation morbidity, and overall survival. The laparoscopic group had a cytoreduction completeness of 86.7 % and an operative morbidity of 13.3 %. Operative mortality occurred for one patient after open surgery.
CONCLUSIONS: Laparoscopic cytoreductive surgery and early postoperative intraperitoneal chemotherapy can be performed safely for selected patients with peritoneal carcinomatosis from colorectal cancer to a limited extent. Further studies with longer follow-up periods and larger numbers of patients are warranted to confirm the study findings.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24368743     DOI: 10.1007/s00464-013-3351-3

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  31 in total

1.  Laparoscopic intraperitoneal hyperthermic chemotherapy for palliation of debilitating malignant ascites.

Authors:  A Garofalo; M Valle; J Garcia; P H Sugarbaker
Journal:  Eur J Surg Oncol       Date:  2006-04-21       Impact factor: 4.424

2.  Analysis of prognostic factors in seventy patients having a complete cytoreduction plus perioperative intraperitoneal chemotherapy for carcinomatosis from colorectal cancer.

Authors:  Rodrigo Gomes da Silva; Paul H Sugarbaker
Journal:  J Am Coll Surg       Date:  2006-10-25       Impact factor: 6.113

3.  Laparoscopic versus open surgery for rectal cancer: long-term oncologic results.

Authors:  Christophe Laurent; Fabien Leblanc; Philippe Wütrich; Mathieu Scheffler; Eric Rullier
Journal:  Ann Surg       Date:  2009-07       Impact factor: 12.969

4.  The role of laparoscopy to evaluate candidates for complete cytoreduction of peritoneal carcinomatosis and hyperthermic intraperitoneal chemotherapy.

Authors:  C Pomel; T-L Appleyard; S Gouy; R Rouzier; D Elias
Journal:  Eur J Surg Oncol       Date:  2005-06       Impact factor: 4.424

5.  Survival after laparoscopic surgery versus open surgery for colon cancer: long-term outcome of a randomised clinical trial.

Authors:  Mark Buunen; Ruben Veldkamp; Wim C J Hop; Esther Kuhry; Johannes Jeekel; Eva Haglind; Lars Påhlman; Miguel A Cuesta; Simon Msika; Mario Morino; Antonio Lacy; Hendrik J Bonjer
Journal:  Lancet Oncol       Date:  2008-12-13       Impact factor: 41.316

6.  Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study.

Authors:  O Glehen; F Kwiatkowski; P H Sugarbaker; D Elias; E A Levine; M De Simone; R Barone; Y Yonemura; F Cavaliere; F Quenet; M Gutman; A A K Tentes; G Lorimier; J L Bernard; J M Bereder; J Porcheron; A Gomez-Portilla; P Shen; M Deraco; P Rat
Journal:  J Clin Oncol       Date:  2004-08-15       Impact factor: 44.544

7.  8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer.

Authors:  Vic J Verwaal; Sjoerd Bruin; Henk Boot; Gooike van Slooten; Harm van Tinteren
Journal:  Ann Surg Oncol       Date:  2008-06-03       Impact factor: 5.344

8.  Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin.

Authors:  Dominique Elias; Jérémie H Lefevre; Julie Chevalier; Antoine Brouquet; Frédéric Marchal; Jean-Marc Classe; Gwenaël Ferron; Jean-Marc Guilloit; Pierre Meeus; Diane Goéré; Julia Bonastre
Journal:  J Clin Oncol       Date:  2008-12-22       Impact factor: 44.544

9.  Randomized clinical trial comparing laparoscopic and open surgery in patients with rectal cancer.

Authors:  J Lujan; G Valero; Q Hernandez; A Sanchez; M D Frutos; P Parrilla
Journal:  Br J Surg       Date:  2009-09       Impact factor: 6.939

10.  Results of systematic second-look surgery in patients at high risk of developing colorectal peritoneal carcinomatosis.

Authors:  Dominique Elias; Diane Goéré; Daniela Di Pietrantonio; Valérie Boige; David Malka; Niaz Kohneh-Shahri; Clarisse Dromain; Michel Ducreux
Journal:  Ann Surg       Date:  2008-03       Impact factor: 12.969

View more
  6 in total

Review 1.  Outcome following incomplete surgical cytoreduction combined with intraperitoneal chemotherapy for colorectal peritoneal metastases.

Authors:  Roisin Mary Heaney; Conor Shields; Jurgen Mulsow
Journal:  World J Gastrointest Oncol       Date:  2015-12-15

2.  Minimally invasive surgery for colorectal cancer, a look back to look forward: a personal history.

Authors:  Gyu-Seog Choi
Journal:  J Minim Invasive Surg       Date:  2022-06-15

3.  A minimally invasive approach for peritonectomy procedures and hyperthermic intraperitoneal chemotherapy (HIPEC) in limited peritoneal carcinomatosis: The American Society of Peritoneal Surface Malignancies (ASPSM) multi-institution analysis.

Authors:  A Arjona-Sanchez; J Esquivel; O Glehen; G Passot; K K Turaga; D Labow; S Rufian-Peña; R Morales; K van der Speeten
Journal:  Surg Endosc       Date:  2018-07-12       Impact factor: 4.584

4.  Cytoreductive Surgery and Intraperitoneal Hyperthermic Chemotherapy (HIPEC) by Minimally Invasive Approach, an Initial Experience.

Authors:  A Arjona-Sanchez; S Rufian-Peña; J M Sanchez-Hidalgo; A Casado-Adam; A Cosano-Alvarez; J Briceño-Delgado
Journal:  World J Surg       Date:  2018-10       Impact factor: 3.352

5.  Laparoscopic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for perforated low-grade appendiceal mucinous neoplasms.

Authors:  Haytham Abudeeb; Chelliah R Selvasekar; Sarah T O'Dwyer; Bipasha Chakrabarty; Lee Malcolmson; Andrew G Renehan; Malcolm S Wilson; Omer Aziz
Journal:  Surg Endosc       Date:  2020-01-28       Impact factor: 4.584

Review 6.  Lobaplatin hyperthermic intraperitoneal chemotherapy plus cytoreduction and rechallenge using cetuximab for wild-type RAS peritoneal metastatic colon cancer: a case report and literature review.

Authors:  Peilin Dai; Zaisheng Ye; Zhai Cai; Zeyu Luo; Enming Qiu; Yu Lin; Jian Cai; Hui Wang; Zhou Li; Shuai Han
Journal:  BMC Gastroenterol       Date:  2022-02-14       Impact factor: 3.067

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.